Kraig Biocraft Laboratories (KBLB) Shares Outstanding (Weighted Average) (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $1.1 billion for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $1.1 billion, up 2.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 billion (up 2.03% YoY), and the FY2025 annual result was $1.1 billion, up 2.03% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.1 billion for Q4 2025 at Kraig Biocraft Laboratories, down from $1.1 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.1 billion in Q3 2025 to a low of $855.1 million in Q1 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.0 billion (2023), against an average of $989.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) grew 12.82% in 2022 and increased 0.3% in 2025, its largest moves.
• Kraig Biocraft Laboratories' Shares Outstanding (Weighted Average) stood at $877.6 million in 2021, then grew by 11.02% to $974.3 million in 2022, then grew by 6.04% to $1.0 billion in 2023, then advanced by 0.51% to $1.0 billion in 2024, then rose by 2.03% to $1.1 billion in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.